Type V Collagen Stimulation Testing in Ex Vivo Human Skin Models
The skincare industry is highly competitive, and demonstrating product efficacy is key to a brand’s success and credibility. Today’s consumers are better informed and want products that do more than make promises: they expect measurable results, especially for wrinkle reduction and restoring skin structure. At the heart of these processes is the extracellular matrix (ECM), a complex protein network in the dermis, and collagen is its main component, giving the skin strength and elasticity.
Type V collagen is attracting particular interest. Although it is present only in small amounts, it plays an important role as a regulator of the organization of type I collagen fibrils, the most abundant collagen. This regulation directly affects the overall structural quality and integrity of the skin. Stimulating the synthesis or activity of type V collagen is therefore a highly attractive target for skincare products that aim to genuinely improve skin structure.
For manufacturers and brand owners, using ex vivo human skin models to evaluate type V collagen stimulation is not only an investment in advanced research and development but also a robust scientific test to support product efficacy claims.
The Role of Type V Collagen in Connective Tissue and Skin
The extracellular matrix (ECM) is a complex network of molecules that provides structural support and biochemical signals to the body’s tissues. Collagens are the most abundant protein family in the ECM and in the mammalian body, accounting for about 25–35% of total protein, and they are essential for the integrity and strength of connective tissues. More than 20 types of collagen have been identified to date, each with its own structure and function.
Type V collagen belongs to the fibrillar collagen subfamily. Although it is present in small amounts compared with other collagens, especially type I collagen, the main structural component of most connective tissues, type V collagen plays a critical role as a regulator of ECM formation and organization, particularly of collagen fibril formation (fibrillogenesis). The functional importance of type V collagen far exceeds its abundance. The fact that even minor defects in this protein can seriously affect connective tissue, as seen in classic Ehlers-Danlos syndrome (cEDS), confirms that a low-abundance component can have a critical regulatory role in the ECM.
Type V collagen is distributed in many connective tissues, including the skin, the body’s largest organ and its first line of defense. In the skin, type V collagen plays an irreplaceable role in maintaining the structure of the dermis, influences the skin’s biomechanical properties such as elasticity and strength (indirectly, by regulating type I collagen fibrils), and takes part in key processes such as wound healing.
Ex Vivo Human Skin Models for Efficacy Testing
An ex vivo human skin model is a full-thickness or partial-thickness piece of human skin obtained from a donor (usually surplus tissue from cosmetic surgery) and cultured in the laboratory under carefully controlled conditions to preserve its viability and physiological structure. The key feature of this model is that it retains the main components of real skin: a fully stratified epidermis, a dermis containing fibroblasts, and other structures such as hair follicles and glands (if present in the tissue sample).
The main advantage of ex vivo models over in vitro models is their much greater physiological relevance. Ex vivo models retain the three-dimensional structure and cellular diversity of skin in its natural environment, unlike cell cultures, which lack the complex architecture and cell–matrix interactions found in real tissue. Compared with in vivo animal models, ex vivo models use human skin directly, so they reflect how human skin responds to test substances more accurately and substantially reduce the ethical concerns associated with animal testing. The test environment can also be controlled more tightly than in vivo studies, allowing the effects of specific variables to be studied precisely.
Evaluating Type V Collagen Stimulation
Type V collagen is tested in ex vivo human skin models using immunofluorescence staining. The staining principle used to evaluate Collagen Type V is Immunofluorescence (IF) — a technique that uses highly specific antibodies to bind to the Collagen Type V protein within the tissue.
The process begins with preparing ex vivo skin samples, usually obtained from surplus surgical tissue with donor consent and ethical approval. The tissue is cleaned, cut into small pieces and cultured under controlled conditions, and then treated with the test substance alongside a control group.
After treatment, the skin samples are fixed, embedded in paraffin and cut into thin sections for IF staining. The sections are incubated with a primary antibody specific to Collagen Type V and then, after the excess antibody has been washed off, with a secondary antibody that carries a fluorescent label and binds to the primary antibody.
Finally, the sections are examined and imaged under a fluorescence microscope. Areas containing Collagen Type V fluoresce, and image analysis software (such as ImageJ) can be used to measure the fluorescence intensity, which reflects the amount of Collagen Type V protein, so the effect of the test substance on Collagen Type V levels can be compared accurately. The method provides specific information on the amount and distribution of Collagen Type V in the skin structure.
Type V Collagen Stimulation Testing: Suitable Samples
Type V collagen is a minor fibrillar collagen found in the dermis. It usually occurs and works together with type I collagen and plays an important role in regulating collagen fibril assembly, fibril size and the overall organization of collagen fibers in the tissue.
Examples of Products, Active Ingredients and Topical Drugs Suitable for This Test
1. Products:
- Anti-wrinkle products
- Products focused on skin quality and smoothness
- Skincare products
2. Active ingredients:
- Peptides: some may be designed to regulate the production of various collagen types, including type V.
- Certain plant extracts or natural substances: those that show potential to improve the structure of the extracellular matrix (ECM), including various collagen types.
- Growth Factors
3. Topical medicines
Literature:
- Tavakoli, S., Kisiel, M. A., Biedermann, T., & Klar, A. S. (2022). Immunomodulation of Skin Repair: Cell-Based Therapeutic Strategies for Skin Replacement (A Comprehensive Review). Biomedicines, 10(1), 118.
- Pfisterer, K., Shaw, L. E., Symmank, D., & Weninger, W. (2021). The Extracellular Matrix in Skin Inflammation and Infection. Frontiers in Cell and Developmental Biology, 9, 682414.